DnaA as a key regulator of ribonucleotide reductase genes in P. aeruginosa. Ángela Martínez-Mateos, Bacterial Infections and Antimicrobial Therapies Group Pseudomonas aeruginosa is a highly adaptable opportunistic pathogen that exhibits … Read more
Your form was submitted.
A study led by the Institute for Bioengineering of Catalonia (IBEC) and the Universitat Autònoma de Barcelona (UAB) has uncovered how co-infection by Pseudomonas aeruginosa and Mycobacterium abscessus, two common lung pathogens, can suppress immune responses and worsen outcomes in patients with respiratory diseases. The findings, published today in the journal Virulence, provide new insight into why polymicrobial infections are particularly difficult to treat and open the door to new therapeutic strategies.
Ref: PR-PG // Deadline: 22/05/2025
The event offers you the opportunity to engage with our researchers and inquire about their day-to-day work in the lab, career trajectories, work-life balance, mobility, etc. In 2024, IBEC signed … Read more
Ref: PHD-MS // Deadline: 19/05/2025
Next Monday we are hosting a group of researchers from the Laboratory of BioNanoTechnology at Wageningen University. Join us for an engaging morning of scientific exchange, with presentations from both … Read more
The new AI is able to predict when and why protein aggregation occurs, a mechanism linked to Alzheimer’s and 50 other diseases that affect 500 million people. The results show great potential for research into neurodegenerative diseases and for improving drug production, reducing costs and increasing efficiency. The study, published today in Science Avances, is the result of a collaboration between the Centre for Genomic Regulation (CRG) and the Institute of Bioengineering of Catalonia (IBEC).